Clinical Trial Update: Quantification of GADD34 Expression in RA [NA]

View source ↗

Summary

A rheumatoid arthritis trial evaluating GADD34 expression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED